Currently out of the existing stock ratings of Arthur He, 84 are a BUY (94.38%), 5 are a HOLD (5.62%).

Arthur He

Work Performance Price Targets & Ratings Chart

Analyst Arthur He, carries an average stock price target met ratio of 21.33% that have a potential upside of 22.06% achieved within 114 days.

Arthur He’s has documented 159 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on VERA, Vera Therapeutics at 08-Jul-2026.

Wall Street Analyst Arthur He

Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for LVTX (LAVA THERAPEUTICS NV) at 8/4/2025. The price target of $1.5 was fulfilled within 1 day with a profit of $0.03 (2.04%) receiving and performance score of 20.41.

Average potential price target upside

of $3.77 (117.82%) on BCAB (BIOATLA ).
of $0.16 (12.14%) on LVTX (LAVA THERAPEUTICS NV).

SLDB Solid Biosciences LLC ADAG Adagene AUPH Aurinia Pharmaceuticals BCAB Bioatla CALT Calliditas Therapeutics LVTX LAVA Therapeutics NV NKTR Nektar Therapeutics PRME Prime Medicine, Common Stock PSTX Poseida Therapeutics VERA Vera Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Arthur He (HC WAINWRIGHT)